2-(4-Fluorobenzyl)acetoacetic acid ethyl ester, 98.0%, 250mg

6-Chloro-2,3-dihydro-1H-indole, 95.0%, 250mg

5-IODO-7-(PHENYLSULFONYL)-7H-PYRROLO[2,3-D]PYRIMIDINE, 95.0%, 10g

4,5-Dichlorophthalonitrile>98.0%(GC)1g

4-Chloro-2-(2,6-dioxopiperidin-3-yl)-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione, 97%, 1g

GC-Kapillarsäule ROTI®Cap-5, unpolar, L 60 m, Ø-Innen 0,25 mm, Filmd. 1,00 µm, 1 Stück

(2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)thiobutyramide sulfate, 98%, 50mg

(5S,8R,9S,10S,13R,14S,17R)-10,13-Dimethyl-17-((R)-6-methylheptan-2-yl)tetradecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one, 97%, 250mg

Ethyl 2-cyano-4,4-diethoxybutyrate, 95.0%, 100g

1-Cyclopropyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid, 95%, 250mg

Ethyl 3-hydroxybenzoate, 98.0%, 1g

2-Naphthonitrile>98.0%(GC)5g

4-Formyl-2-methoxybenzonitrile, 97%, 10g